Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: A review of human studies

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 4-6, 2010, Pages 305-314

  Ryan, Alan S ^a   Astwood, James D ^a   Gautier, Sheila ^a   Kuratko, Connye N ^a   Nelson, Edward B ^a   Salem, Norman ^a  

^a Martek Biosciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; COD LIVER OIL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; TRACE ELEMENT;

ARTICLE; BIPOLAR DISORDER; BREAST FEEDING; CHILD DEVELOPMENT; CHILD GROWTH; CHILD NUTRITION; CHILDHOOD DISEASE; CLINICAL TRIAL; COGNITION; DIET SUPPLEMENTATION; DRUG EFFICACY; EARLY CHILDHOOD INTERVENTION; EPIDEMIOLOGICAL DATA; FAT INTAKE; FATTY ACID BLOOD LEVEL; HUMAN; LACTATION; MENTAL DISEASE; MOTOR PERFORMANCE; NERVE CELL DIFFERENTIATION; OUTCOME ASSESSMENT; PHENYLKETONURIA; PREGNANCY; PRIORITY JOURNAL; THERAPY EFFECT; VISION TEST;

BRAIN; CHILD; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY;

EID: 77951979020     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.02.007     Document Type: Article

References (78)

1. Belkind-Gerson J., Carreón-Rodríguez A., Contreras-Ochoa C.O., Estrada- Mondaca S., Parra-Cabrera M.S. Fatty acids and neurodevelopment. J. Pediatr. Gastroenterol. Nutr. 2008, 47:S7-S9.
2. Innis S.M. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008, 1237:35-43.
3. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992, 120:S129-S138.
4. Dobbing J., Sands J. Quantitative growth and development of human brain. Arch. Dis. Child. 1973, 48:757-767.
5. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 1980, 4:121-129.
6. Koletzko B., Larque E., Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J. Perinat. Med. 2007, 35:S5-S11.
7. Vaidyanathan V.V., Rao K.V., Sastry P.S. Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid. Neurosci. Lett. 1994, 179:171-174.
8. Poling J.S., Karanian J.W., Salem N., Vicini S. Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid. Mol. Pharmacol. 1995, 47:381-390.
9. Delion S., Chalon S., Guilloteau D., Besnard J.C., Durand G. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J. Neurochem. 1996, 66:1582-1591.
10. Litman B.J., Mitchell D.C. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 1996, 31(Suppl.):S193-S197.
11. Chalon S., Delion-Vancassel S., Belzung C., et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J. Nutr. 1998, 128:2512-2519.
12. Simmer K., Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst. Rev. 2004, 1.
13. SanGiovanni J.P., Parra-Cabrera S., Colditz G.A., Berkey C.S., Dwyer J.T. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000, 105:1292-1298.
14. Clandinin M.T., Aerde J.E., Merkel K.L., et al. Growth and development of preterm infants fed infant formula containing docosahexaenoic acid and arachidonic acid. J. Pediatr. 2005, 146:461-468.
15. Makrides M., Gibson R.A., McPhee A.J., et al. Neurodevelopmental outcome of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009, 301:175-182.
16. Simmer K. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. 2001, 4. CD000376.
17. SanGiovanni J.P., Berker C.S., Dwyer J.T., Colditz G.A. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infant: a systematic review. Early Hum. Dev. 2000, 57:165-188.
18. Hoffman D.R., Boettcher J.A., Diersen-Schade D.A. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:151-158.
19. Eilander A., Hundscheid D.C., Osendarp S.J., Transler C., Zock P.L. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76:189-203.
20. Innis S.M., Vaghri Z., King D.J. n-6 Docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. Am. J. Clin. Nutr. 2004, 80:768-773.
21. Levitt P. Structural and functional maturation of the developing primate brain. J. Pediatr. 2003, 143:335-345.
22. Chugani H.T. A critical period of brain development: studies of cerebral glucose utilization with PET. Prev. Med. 1998, 27:184-188.
23. Oyster C.W. The Human Eye-Structure and Function 1999, Sinauer Associates Inc., Sunderland, MA.
24. Lien V.W., Clandinin M.T. Dietary assessment of arachidonic acid and docosahexaenoic acid intake in 4-7 year-old children. J. Am. Coll. Nutr. 2009, 28:7-15.
25. Institute of Medicine Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids 2002, National Academy Press, Washington, DC.
26. Kris-Etherton P.M., Innis S. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J. Am. Diet. Assoc. 2007, 107:1599-1611.
27. Harris W.S., Mozaffarian D., Lefevre M., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosapentaenoic acids. J. Nutr. 2009, 139:804S-819S.
28. Scientific Advisory Committee on Nutrition The Nutritional Wellbeing of the British Population 2008, The Stationary Office, Norwich, UK.
29. European Food Safety Authority, Draft scientific opinion of the Panel of Dietetic Products, Nutrition and Allergies on a request from the European Commission related to dietary reference values for fats, EFSA J. 1-97, in press.
30. Madden S.M.M., Gerrioch C.F., Holub B.J. Direct diet quantification indicates low intakes of (n-3) fatty acids in children 4 to 8 years old. J. Nutr. 2009, 139:1-5.
31. Sichert-Hellert W., Wicher M., Kersting M. Age and time trends in fish consumption patterns of children and adolescents, and consequences for the intake of long-chain n-3 polyunsaturated fatty acids. Eur. J. Clin. Nutr. 2009, 63:1071-1075.
32. United States Department of Agriculture, 1994-96 Continuing Survey of Food Intakes by Individuals and Diet and Health Knowledge Survey, Accessed June 2009, Available at: http://www.barc.usda.gov/bhnrc/foodsurvey/home.htm.
33. Bakker E.C., Ghys A.J.A., Kester A.D.M., et al. Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 years of age. Eur. J. Clin. Nutr. 2003, 57:89-95.
34. Ghys A., Bakker E., Hornstra G., van den Hout M. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum. Dev. 2002, 69:83-90.
35. Bakker E.C., Hornstra G., Blanco C.E., Vles J.S.H. Relationship between long-chain polyunsaturated fatty acids at birth and motor function at 7 years of age. Eur. J. Clin. Nutr. 2009, 63:499-504.
36. Touwen B.C.L. Examination of the Child with Minor Neurological Dysfunction 1979, Spastics International Medical Publications, London.
37. Zhang J., Hebert J.R., Muldoon M.F. Dietary fat intake is associated with psychosocial and cognitive functioning of school-aged children in the United States. J. Nutr. 2005, 135:1967-1973.
38. Whalley L.J., Fox H.C., Wahle K.W., Starr J.M., Deary I.J. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am. J. Clin. Nutr. 2004, 80:1650-1657.
39. Aberg M.A., Aberg N., Brisman J., Sundberg R., Winkvist A., Toren K. Fish intake of Swedish male adolescents is a predictor of cognitive performance. Acta Paediatr. 2009, 98:555-560.
40. Cohen J.T., Bellinger D.C., Connor W.E., Shaywitz B.A. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development. Am. J. Prev. Med. 2005, 29:366-374.
41. Hibbeln J.R., Davis J.N., Steer C., et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC): an observational study. Lancet 2007, 369:578-585.
42. Oken E., Radesky J.S., Wright R.O., et al. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am. J. Epidemiol. 2008, 167:1171-1181.
43. Oken E., Østerdal M.L., Gillman M.W., et al. Associations of maternal fish intake during pregnancy and breastfeeding duration with attainment of developmental milestones in early childhood: a study from the Danish National Birth Cohort. Am. J. Clin. Nutr. 2008, 88:789-796.
44. Budtz-Jorgensen E., Grandjean P., Weihe P. Separation of risks and benefits of seafood intake. Environ. Health Perspect. 2007, 115:323-327.
45. US Department of Health and Human Services, What you need to know about mercury in fish and shellfish, March 2004. Internet: , accessed 10 November 2009. http://www.cfsan.fda.gov/~dms/admehg3.html.
46. Koletzko B., Cetin I., Brenna J.T. Dietary fat intake for pregnant and lactating women. Br. J. Nutr. 2008, 36:5-14.
47. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39-e44.
48. Dunstan J.A., Simmer K., Dixon G., Prescott S.L. Cognitive assessment of children at age 21\2 years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 2008, 93:F45-F50.
49. The Nemo Study Group Effect of a 12-Mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am. J. Clin. Nutr. 2007, 86:1082-1093.
50. Walker S.P., Wachs T.D., Gardner J.M., et al. Child development: risk factors for adverse outcomes in developing countries. Lancet 2007, 369:145-157.
51. Muthayya S., Eilander A., Transler C., et al. Effect of fortification with multiple micronutrients and n-3 fatty acids on growth and cognitive performance in Indian schoolchildren: the CHAMPION (Children's Health and Mental Performance Influenced by Optimal Nutrition) Study. Am. J. Clin. Nutr. 2009, 89:1-10.
52. Ryan A.S., Nelson E.B. Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study. Clin. Pediatr. 2008, 47:355-362.
53. Bailey-Hall E., Nelson E.B., Ryan A.S. Validation of a rapid measure of blood PUFA levels in humans. Lipids 2008, 43:181-186.
54. Arterburn L.M., Bailey Hall E., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids. Am. J. Clin. Nutr. 2006, 83:1467S-1476S.
55. Dalton A., Wolmarans P., Witthuhn R.C., van Stuijvenberg M.E., Swanevelder S.A., Smuts C.M. A randomized control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80:143-149.
56. R.K. McNamara, J. Able, M.P.R. Jandacek, et al., Docosahexaenoic acid supplementation augments prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled dose ranging fMRI study, Am. J. Clin. Nutr., doi:10.3945/ajcn.2009.28549.
57. Kennedy D.O., Jackson P.A., Elliot J.M., et al. Cognitive and mood effects of 8 weeks' supplementation with 400mg or 1000mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years. Nutr. Neurosci. 2009, 12:48-56.
58. Yannicelli S., Ryan A.S. Improvements in behavior and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine restricted diet: a national survey. J. Inherit. Metab. Dis. 1995, 18:131-134.
59. Giovannini B., Biasucci G., Agostoni C., Luotti D., Riva E. Lipid status and fatty acid metabolism in phenylketonuria. J. Inherit. Metab. Dis. 1995, 18:265-272.
60. Burgard P., Schmidt E., Rupp A., Schneider W., Bremer H.J. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur. J. Pediatr. 1996, 155(suppl):S33-S38.
61. Stemerdink B.A., Kalverboer A.F., van der Meere J.J., et al. Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J. Inherit. Metab. Dis. 2000, 23:548-562.
62. Agostoni C., Massetto N., Biasucci G., et al. Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J. Pediatr. 2000, 137:504-509.
63. Beblo S., Reinhardt H., Muntau A.C., Mueller-Felber W., Roscher A.A., Koletzko B. Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 2001, 57:1488-1491.
64. Koletzko B., Beblo S., Demmelmair H., Hanebutt F.L. Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU). J. Pediatr. Gastroenterol. Nutr. 2009, 48:S2-S7.
65. Beblo S., Reinhardt H., Demmelmair H., Muntau A.C., Koletzko B. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J. Pediatr. 2007, 150:479-484.
66. Stevens L., Zhang W., Peck L., et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive disorders. Lipids 2003, 38:1007-1021.
67. Colter A.L., Cutler C., Meckling K.A. Fatty acid status and behavioral symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr. J. 2008, 7:8. 10.1186/1475-2891-7-8.
68. Maes M., Smith R., Christophe A., Cosyns P., Desnyder R., Meltzer H. Fatty acid comparison in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J. Affect. Disord. 1996, 26:35-46.
69. P. Montgomery, A.J. Richardson, Omega-3 fatty acids for bipolar disorder, Cochrane Database Syst. Rev. 2008, Issue 2, Art. no. CD005169.
70. Frangou S., Lewis M., McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomized double-blind placebo-controlled study. Br. J. Psychiatry 2006, 75:315-321.
71. Stoll A.L., Severus W.E., Freeman M.P., et al. Omega 3 fatty acids in bipolar disorder. Arch. Gen. Psychiatry 1999, 56:407-412.
72. Freeman M.P., Hibbeln J.R., Wisner K.L., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 2006, 67:1954-1967.
73. Bekaroglu M., Asian Y., Gedik Y. Relationship between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J. Child. Psychol. Psychiatry 1996, 37:225-227.
74. Voigt R.G., Llorente A.M., Jensen C.L., Frayley J.K., Berretta M.C., Heird W.C. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J. Pediatr. 2001, 139:189-196.
75. Richardson A.J., Puri B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:233-239.
76. Richardson A.J., Montgomery P. The Oxford-Durham Study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 2005, 115:1360-1366.
77. Lin P.-Y., Su K.-P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry 2007, 68:1056-1061.
78. Raz R., Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev. Med. Child. Neurol. 2009, 51:580-592.